COMPARISON OF HEALTHCARE COSTS IN FRANCE OF COMBINATION NIVOLUMAB AND IPILIMUMAB TREATMENT VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA

被引：0
|
作者：
Bregman, B. [1 ]
Moshyk, A. [2 ]
Johnson, H. M. [3 ]
Potluri, R. [4 ]
Bhandari, H. [5 ]
Ranjan, S. [5 ]
机构：
[1] Bristol Myers Squibb, Rueil Malmaison 92, France
[2] Bristol Myers Squibb, Lawrenceville, NJ USA
[3] Bristol Myers Squibb, Uxbridge, Middx, England
[4] SmartAnalyst Inc, New York, NY USA
[5] SmartAnalyst India Pvt Ltd, Gurgaon, India
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN105
引用
收藏
页码：S441 / S441
页数：1
相关论文
共 50 条
  • [1] HEALTHCARE COST COMPARISON ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA
    Potluri, R.
    Bhandari, H.
    Ranjan, S.
    Moshyk, A.
    Kotapati, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S72 - S73
  • [2] Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
    Ravi Potluri
    Sandip Ranjan
    Hitesh Bhandari
    Helen Johnson
    Andriy Moshyk
    Srividya Kotapati
    [J]. Experimental Hematology & Oncology, 8
  • [3] Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
    Potluri, Ravi
    Ranjan, Sandip
    Bhandari, Hitesh
    Johnson, Helen
    Moshyk, Andriy
    Kotapati, Srividya
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (1)
  • [4] Immunomodulatory effects of nivolumab and ipilimumab in combination or nivolumab monotherapy in advanced melanoma patients: CheckMate 038
    Ribas, Antoni
    Martin-Algarra, Salvador
    Bhatia, Shailender
    Hwu, Wen-Jen
    Slingluff, Craig L.
    Sharfman, William H.
    Hodi, F. Stephen
    Urba, Walter J.
    Luke, Jason J.
    Haanen, John B.
    Callahan, Margaret K.
    Wolchok, Jedd D.
    Chasalow, Scott D.
    Ross-Macdonald, Petra
    Young, Tina C.
    Qureshi, Anila
    Horak, Christine E.
    [J]. CANCER RESEARCH, 2017, 77
  • [5] Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
    Larkin, J.
    Chiarion-Sileni, V.
    Gonzalez, R.
    Grob, J. J.
    Cowey, C. L.
    Lao, C. D.
    Schadendorf, D.
    Dummer, R.
    Smylie, M.
    Rutkowski, P.
    Ferrucci, P. F.
    Hill, A.
    Wagstaff, J.
    Carlino, M. S.
    Haanen, J. B.
    Maio, M.
    Marquez-Rodas, I.
    McArthur, G. A.
    Ascierto, P. A.
    Long, G. V.
    Callahan, M. K.
    Postow, M. A.
    Grossmann, K.
    Sznol, M.
    Dreno, B.
    Bastholt, L.
    Yang, A.
    Rollin, L. M.
    Horak, C.
    Hodi, F. S.
    Wolchok, J. D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (01): : 23 - 34
  • [6] Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
    Valsecchi, Matias E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13): : 1270 - 1270
  • [7] Nivolumab in combination with ipilimumab for the treatment of melanoma
    Somasundaram, Rajasekharan
    Herlyn, Meenhard
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (10) : 1135 - 1141
  • [8] Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
    Postow, Michael A.
    Chesney, Jason
    Pavlick, Anna C.
    Robert, Caroline
    Grossmann, Kenneth
    McDermott, David
    Linette, Gerald P.
    Meyer, Nicolas
    Giguere, Jeffrey K.
    Agarwala, Sanjiv S.
    Shaheen, Montaser
    Ernstoff, Marc S.
    Minor, David
    Salama, April K.
    Taylor, Matthew
    Ott, Patrick A.
    Rollin, Linda M.
    Horak, Christine
    Gagnier, Paul
    Wolchok, Jedd D.
    Hodi, F. Stephen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21): : 2006 - 2017
  • [9] Nivolumab and Ipilimumab in Advanced Melanoma
    Ryu, Hyewon
    Lee, Hyo Jin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (25): : 2503 - 2503
  • [10] Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal
    Wan, M. T.
    Ming, M. E.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (02) : 296 - 300
12345